Because the trial ended up being underpowered, it did not show a benefit of intensive medical treatment, but there was a high ...

Remote interventions may reduce relapse and the number of days of substance use when supplementing in-person care, but ...

Inebilizumab-cdon was previously approved by the FDA for neuromyelitis optica spectrum disorder (NMOSD) in adults who are anti-aquaporin-4 antibody positive, in 2020. It has also been designated as an ...

A parliamentary report warned of a continuing crisis in NHS dentistry, with government recovery plans having ‘comprehensively ...